Adding PD-1 inhibition to chemoradiotherapy for oesophageal cancer

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Access to Document

@article{739ed0ead2514811b3e6da62c0b4518f,

title = "Adding PD-1 inhibition to chemoradiotherapy for oesophageal cancer",

author = "{van Laarhoven}, {Hanneke W. M.} and {van Rossum}, {Peter S. N.}",

year = "2023",

month = apr,

day = "1",

doi = "10.1016/S1470-2045(23)00103-1",

language = "English",

volume = "24",

pages = "309--310",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "4",

}

TY - JOUR

T1 - Adding PD-1 inhibition to chemoradiotherapy for oesophageal cancer

AU - van Laarhoven, Hanneke W. M.

AU - van Rossum, Peter S. N.

PY - 2023/4/1

Y1 - 2023/4/1

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150912569&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/36990605

U2 - 10.1016/S1470-2045(23)00103-1

DO - 10.1016/S1470-2045(23)00103-1

M3 - Comment/Letter to the editor

C2 - 36990605

SN - 1470-2045

VL - 24

SP - 309

EP - 310

JO - Lancet Oncology

JF - Lancet Oncology

IS - 4

ER -